miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1
miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1
复制标题
miR-508-5p通过靶向ABCB1和ZNRD1调控胃癌多药耐药
DOI:
10.1038/onc.2013.297
复制
发表时间:
2014-06-19
期刊:
影响因子:
8
通讯作者:
Fan, D.
中科院分区:
文献类型:
--
作者:
Shang, Y.;Zhang, Z.;Fan, D.
Multidrug resistance (MDR) is usually correlated with the poor prognosis of gastric cancer. In this study, we revealed a total of 11 microRNAs (miRNA) that regulated MDR of gastric cancer via high-throughput functional screening, and miR-508-5p reversed MDR most efficiently among these candidate miRNAs. The overexpression of miR-508-5p was sufficient to reverse cancer cell resistance to multiple chemotherapeutics in vitro and sensitize tumours to chemotherapy in vivo. Further studies showed that miR-508-5p could directly target the 3′-untranslated regions of ABCB1 and Zinc ribbon domain-containing 1 (ZNRD1), and suppress their expression at the mRNA and protein levels. Meanwhile, the suppression of ZNRD1 led to a decrease in ABCB1. These findings suggest that a miR-508-5p/ZNRD1/ABCB1 regulatory loop has a critical role in MDR in gastric cancer. In addition, miR-508-5p could be used as a prognostic factor for overall survival in gastric cancer. These data reveal an important role for miR-508-5p in the regulation of MDR in gastric cancer, and suggest the potential application of miR-508-5p in drug resistance prediction and treatment.